Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
Search by expertise, name or affiliation
New Agents for Treatment of Dyslipidemia
Vinaya Simha
Endocrinology, Diabetes, Metabolism, and Nutrition
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'New Agents for Treatment of Dyslipidemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Proprotein Convertase 9
100%
Dyslipidemias
66%
Cardiovascular Diseases
49%
LDL Receptors
26%
Recycling
26%
LDL Lipoproteins
23%
Mortality
22%
Hydroxymethylglutaryl-CoA Reductase Inhibitors
22%
Lipoproteins
21%
LDL Cholesterol
20%
Hepatocytes
19%
Triglycerides
18%
Diabetes Mellitus
18%
Type 2 Diabetes Mellitus
17%
Cholesterol
16%
Lipids
14%
Clinical Trials
14%
Membranes
13%
Morbidity
13%
Blood Vessels
13%
Therapeutics
11%
Incidence
11%
Pharmaceutical Preparations
9%
Population
8%